Previous close | 1.3700 |
Open | 1.6800 |
Bid | 1.7000 |
Ask | 2.1400 |
Strike | 100.00 |
Expiry date | 2024-08-02 |
Day's range | 1.5500 - 1.6800 |
Contract range | N/A |
Volume | |
Open interest | 39 |
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergGavin Newsom Is Ready for the Biden EmergencyPanicked Emails, Gallows Humor: The Aftermath of Biden's Debate DisasterThe Question on Democrats’ Minds: How to Replace Biden?Biden’s Disastrous Debate Accelerates Doubts Over CandidacySupreme Court Overturns Chevron
NEW YORK, June 28, 2024--Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2024.
Morgan Stanley hit with cash-sweep suit. Morgan Stanley pays an interest rate of as little as 0.01% on customers’ uninvested cash in its default bank sweep program. Morgan Stanley declined to comment on the case.